Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The overall goal of this study is to evaluate the use of dopamine transporter (DAT) imaging as a diagnostic tool in subjects with early parkinsonian symptoms, in whom Parkinson's disease (PD) or parkinsonian syndrome (PS) is suspected, but the diagnosis remains unclear from a clinical standpoint.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institute for Neurodegenerative Disorders
• Collaborator: Molecular NeuroImaging

Criteria

Inclusion Criteria:

• Age >21

• Any parkinsonian or extrapyramidal symptoms

• Parkinsonian symptoms for < 2 years duration.

• No significant abnormalities on screening laboratory studies including: CBC, Chem-20 and urinalysis.

• Willingness to comply with study protocol.

Exclusion Criteria:

• Pregnancy

• Significant medical disease including abnormalities on screening biochemical or hematological labs or abnormal electrocardiogram (ECG).